CAS: 80168-44-1; 1-{(2E)-2-(5-Chloro-2-Thienyl)-2-[(2,6-Dichlorophenyl)Hydrazono]E Thyl}-1H-Imidazole

上下游产品

(2,6-dichlorophenyl)hydrazine monohydr°Chloride 1-(5-chloro-thiophen-2-yl)-2-imidazol-1-yl-ethanone(Z)-1-(5-chlorothien-2-yl)-2-(1H-imidazol-1-yl)ethanone 2,6-dichlorophenylhydrazone hydr°Chloride

📜2,6-二氯苯肼盐酸盐,1-(5-氯-噻吩-2-基)-2-咪唑-1-基-乙酮 以 乙醇,甲苯 作为反应溶剂,化学反应生成 (E)-1-(5-氯-2-噻吩基-2-(1H)-咪唑-1-基)乙酮(2,6-二氯苯基)腙盐酸盐
参考文献:Imidazole Hydrazone Derivatives
标题:Imidazole Hydrazone Derivatives
摘要:化合物对应以下的一般式:##str1## 其中ar和ar.Sup.1,可以相同也可以不同,每个代表一个芳香基团,可以被卤素和/或硝基和/或较低的烷基和/或三卤甲基和/或氰基和/或较低的烷氧基和/或二较低的烷基氨基取代,烷基可以选择完成一个环,该环可以包含进一步的杂原子和/或较低的烷基磺酰基;alk.Sup.1和alk.Sup.2,可以相同也可以不同,每个代表一个含有一到八个碳原子的烷基,可以被苯基和/或环烷基和/或较低的烷基取代,如果存在两个这样的烷基,则它们可以完成一个环,该环可以包含一个杂原子,且咪唑环可以被进一步取代;m代表0或1;前提是ar和ar.Sup.1不能同时代表苯基;以及其酸加成盐.这些化合物通过以下一般式的化合物与以下式的化合物的反应制备而成:##str2## 这些化合物具有抗真菌活性以及抗厌氧和抗血栓活性.

专利信息

专利号:US-2014315720-A1
优先权日:2012-10-24
标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
发明人：FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
权利人:CELANESE ACETATE LLC
摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.